Evidence map›Paper›PMID 40904756›Full record

ArticleJournal of medical cases2025

A Clinical Case of Methotrexate Toxicity.

Ana Cristina Peixoto, Rodrigo de Almeida Mota, Ana Luisa Maceda Rodrigues, Margarida Miguel Paraiso, Leila Amaro Cardoso, Jorge Almeida

Abstract readCase Reports
In one paragraph

Article in Journal of medical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ana Cristina PeixotoInternal Medicine Department, Unidade Local de Saude de Sao Joao, Alameda Professor Hernani Monteiro, 4200-319 Porto, Portugal.ORCID https://orcid.org/0009-0007-5132-0791
Rodrigo de Almeida MotaInternal Medicine Department, Unidade Local de Saude de Sao Joao, Alameda Professor Hernani Monteiro, 4200-319 Porto, Portugal.
Ana Luisa Maceda RodriguesInternal Medicine Department, Unidade Local de Saude de Sao Joao, Alameda Professor Hernani Monteiro, 4200-319 Porto, Portugal.
Margarida Miguel ParaisoInternal Medicine Department, Unidade Local de Saude de Sao Joao, Alameda Professor Hernani Monteiro, 4200-319 Porto, Portugal.
Leila Amaro CardosoInternal Medicine Department, Unidade Local de Saude de Sao Joao, Alameda Professor Hernani Monteiro, 4200-319 Porto, Portugal.ORCID https://orcid.org/0000-0002-0209-3146
Jorge AlmeidaInternal Medicine Department, Unidade Local de Saude de Sao Joao, Alameda Professor Hernani Monteiro, 4200-319 Porto, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methotrexate is a commonly prescribed immunosuppressant and chemotherapy agent, carefully monitored by healthcare providers due to its potential adverse effects. As a result, methotrexate toxicity is relatively rare. We present the case of a 79-year-old man followed in rheumatology for symmetrical polyarthralgia, who inadvertently took methotrexate 10 mg daily, instead of weekly, leading to methotrexate toxicity. The patient presented with erosive mucositis affecting the lateral tongue, buccal mucosa, and hard palate, as well as pustular lesions on the scalp (occipital and cervical regions) extending to the trunk. Laboratory findings revealed pancytopenia and transaminitis, and upper gastrointestinal endoscopy showed erythema and superficial ulcerations in the oropharyngeal region. Methotrexate was discontinued immediately, and the patient was treated with intravenous fluids, filgrastim, and supportive care. This case highlights the importance of early recognition of methotrexate toxicity, as well as the critical role of patient education. It underscores how easily a medication with numerous therapeutic benefits can cause serious adverse outcomes if not taken as prescribed. Effective communication between healthcare providers and patients is essential to ensure medication safety.

Indexed as

Methotrexate toxicityMyelosuppressionPancytopenia

Identifiers

PMID40904756
PMCPMC12404118

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.